A retrospective study to evaluate efficacy of switching to intravitreal aflibercept in patients with macular oedema secondary to central retinal vein occlusion who received prior treatment with intravitreal ranibizumab or bevacizumab therapy

A retrospective study to evaluate efficacy of switching to intravitreal aflibercept in patients with macular oedema secondary to central retinal vein occlusion who received prior treatment with intravitreal ranibizumab or bevacizumab therapy

Completed

Phase of Trial:
Phase IV

Latest Information Update:15 Oct 2016

At a glance

Drugs
Aflibercept (Primary)

Indications
Central retinal vein occlusion; Retinal oedema

Focus
Therapeutic Use

Most Recent Events

15 Oct 2016
New trial record

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login
with a username/password associated to an account with a valid subscription